CID 16131947

Hiv-1 12-mer tar rna containing 2'-o-methoxynucleotides and 2',4'-locked .alpha.-l-nucleotides: 5'-[.alpha.-l-lna(c)-2'-ome(u)-.alpha.-l-lna(c)-2'-ome(c)-.alpha.-l-lna(c)-2'-ome(a)-2'ome(g)-2'-ome(g)-.alphal-lna(c)-2'-ome(u).alpha.-l-lna(c)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C154H186N44O92P12
SMILES
CC1=CN(C(=O)N=C1N)C2C3C(C(O2)(CO3)CO)OP(=O)(O)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)OC)OP(=O)(O)OCC67COC(C6OP(=O)(O)OCC8C(C(C(O8)N9C=CC(=NC9=O)N)OC)OP(=O)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C(N=CN=C31)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC13COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=O)(O)OCC14COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC5=C(N=CN=C51)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC5=C(C=C1)C(=O)OC51C5=C(C=C(C=C5)O)OC5=C1C=CC(=C5)O)C(O4)N1C=C(C(=NC1=O)N)C)C(O3)N1C=C(C(=NC1=O)N)C)C(O2)N1C=C(C(=NC1=O)N)C)C(O7)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C154H186N44O92P12/c1-58-30-190(144(212)178-111(58)156)133-101-106(149(42-199,273-133)43-248-101)286-294(223,224)256-37-74-88(95(242-7)127(267-74)188-24-20-81(202)176-142(188)210)283-300(235,236)262-49-150-44-249-102(134(274-150)191-31-59(2)112(157)179-145(191)213)107(150)287-295(225,226)257-38-73-87(94(241-6)126(266-73)187-23-19-80(155)175-141(187)209)282-299(233,234)261-48-151-45-251-105(137(275-151)194-34-62(5)115(160)182-148(194)216)110(151)290-298(231,232)260-41-79-91(98(245-10)130(270-79)196-55-171-84-117(162)167-53-169-120(84)196)280-292(219,220)254-35-76-92(99(246-11)131(271-76)197-56-172-85-121(197)183-139(164)185-124(85)206)281-293(221,222)255-36-77-93(100(247-12)132(272-77)198-57-173-86-122(198)184-140(165)186-125(86)207)285-302(239,240)264-51-153-47-252-103(135(277-153)192-32-60(3)113(158)180-146(192)214)108(153)288-296(227,228)258-39-75-89(96(243-8)128(268-75)189-25-21-82(203)177-143(189)211)284-301(237,238)263-50-152-46-250-104(136(276-152)193-33-61(4)114(159)181-147(193)215)109(152)289-297(229,230)259-40-78-90(97(244-9)129(269-78)195-54-170-83-116(161)166-52-168-119(83)195)279-291(217,218)253-26-22-70(118(163)204)174-123(205)63-13-16-66-69(27-63)154(278-138(66)208)67-17-14-64(200)28-71(67)265-72-29-65(201)15-18-68(72)154/h13-21,23-25,27-34,52-57,70,73-79,87-110,126-137,199-201H,22,26,35-51H2,1-12H3,(H2,163,204)(H,174,205)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H,239,240)(H2,155,175,209)(H2,156,178,212)(H2,157,179,213)(H2,158,180,214)(H2,159,181,215)(H2,160,182,216)(H2,161,166,168)(H2,162,167,169)(H,176,202,210)(H,177,203,211)(H3,164,183,185,206)(H3,165,184,186,207)/t70-,73?,74?,75?,76?,77?,78?,79?,87?,88?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,109?,110?,126?,127?,128?,129?,130?,131?,132?,133?,134?,135?,136?,137?,149?,150?,151?,152?,153?/m0/s1
InChIKey
CVQOLECEWGCPIL-FGTGYIQRSA-N
Compound name
[3-[[7-[[3-[[7-[[3-[[3-[[3-[[7-[[3-[[7-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methyl [3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4494.808 Da
Monoisotopic Mass

-29.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4495.8153 312.5
[M+Na]+ 4517.7972 312.7
[M-H]- 4493.8007 312.5
[M+NH4]+ 4512.8418 312.5
[M+K]+ 4533.7712 312.5
[M+H-H2O]+ 4477.8053 312.2
[M+HCOO]- 4539.8062 312.5
[M+CH3COO]- 4553.8219 312.5
[M+Na-2H]- 4515.7827 312.8
[M]+ 4494.8075 312.7
[M]- 4494.8085 312.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.